Development anomalies of the aortic arch and its major branches are rare congenital cardiovascular disorders. In this article, we present aberrant left subclavian artery associated with right aortic arch.
Right aortic arch (RAA) is a rare malformation and is reported at a range of 0.04 to 0.1% in autopsy series. 1 The anomaly occurs in embryonic life due to the persistence of the right-fourth aortic arch, while regressing the left-fourth arch between the left common carotid artery and the left subclavian artery. 2 There are three types of the right-sided aortic arch as follows: Type I involves right aortic arch with mirror image branching, Type II involves right aortic arch with aberrant left subclavian artery, and Type III involves right-sided aortic arch with isolated left subclavian artery communicating with the pulmonary artery. 3 Right aortic arch is generally an asymptomatic malformation and diagnosed incidentally. In the Type II form, in which the left subclavian artery is aberrant (►Video 1), patients may present to the clinic with the symptoms occurring secondary to trachea or esophagus compression or aneurysm or dissection of the vessels. 1 Dysphagia and dyspnea are usually the symptoms at the infant period, whereas atherosclerotic changes, dissection, or aneurysm may be seen in adulthood. 1, 3, 4 Video 1
Computed tomography angiography video shows right aortic arch with aberrant left subclavian artery. Online content including video sequences viewable at: https:// www.thieme-connect.com/products/ejournals/html/ 10.1055/s-0039-3401999. speed of scanning (►Figs. 1 and 2). Also, magnetic resonance imaging is another option which may be used for diagnosis. 5 The complications of this pathology include aneurysm formation and dissection which may be secondary to atherosclerosis in latter ages, as well as recurrent lower respiratory tract infections, and growth retardation in the early years of childhood 3 ; hence, these patients should be followed-up lifelong.
In conclusion, the symptoms are the most important determinants for the treatment of the patients with RAA. Careful follow-up is necessary for the prevention of fatal complications. 
